Petros Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)12holders −1
2new positions
3sold out
$0.46avg. 13F price*
At the end of Q2 2024, 12 institutions reported holding Petros Pharmaceuticals Inc. in their 13F filings, down 1 from Q1 2024. 2 opened new positions and 3 sold out. The largest holders were Virtu Financial LLC ($32K), Two Sigma Securities, LLC ($25K) and Vanguard Group Inc. ($15K).
- Company
- Petros Pharmaceuticals Inc.
- CUSIP
- 71678J209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $57K |
| Exits | 3 | $217 |
All 13F filers, Q1 2024 → Q2 2024: 144,053 shares bought and 757 shares sold, net +143,296 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Virtu Financial LLC | 0.00% | New | 70,256 | $32K |
| Two Sigma Securities, LLC | 0.00% | New | 53,876 | $25K |
| Vanguard Group Inc. | 0.00% | No change | 31,811 | $15K |
| Geode Capital Management, LLC | 0.00% | Add +189.2% | 30,370 | $14K |
| BlackRock Inc. | 0.00% | No change | 16,510 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -3.6% | 3,274 | $1K |
| Emfo, LLC | 0.00% | No change | 1,000 | $458 |
| National Bank of Canada | 0.00% | No change | 313 | $136 |
| Group One Trading LLC | 0.00% | No change | 79 | $36 |
| Bank of America Corp. | 0.00% | Add +5300.0% | 54 | $25 |
| Morgan Stanley | 0.00% | Reduce -96.3% | 19 | $9 |
| 1832 Asset Management L.P. | 0.00% | No change | 10 | $5 |
"% of holder's portfolio" is PETROS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Petros Pharmaceuticals Inc. the manager owns.